PSCH vs. PBPH
PSCH (Invesco S&P SmallCap Health Care ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - PSCH tracks the S&P SmallCap 600 Health Care Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. At a 0.50 correlation, their price movements are largely independent. PSCH charges 0.29%/yr vs 0.13%/yr for PBPH.
Performance
PSCH vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PSCH achieves a 1.80% return, which is significantly higher than PBPH's -1.13% return.
PSCH
- 1D
- 1.28%
- 1M
- -0.71%
- YTD
- 1.80%
- 6M
- -1.68%
- 1Y
- 10.18%
- 3Y*
- 0.45%
- 5Y*
- -5.72%
- 10Y*
- 6.81%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PSCH vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 1.80% | -3.68% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between PSCH and PBPH is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.50 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSCH vs. PBPH — Risk / Return Rank
PSCH
PBPH
PSCH vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSCH | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.10 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 0.67 | — | — |
| Martin ratioReturn relative to average drawdown | 1.84 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PSCH | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.51 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.25 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | -0.04 | +0.56 |
Drawdowns
PSCH vs. PBPH - Drawdown Comparison
The maximum PSCH drawdown since its inception was -46.32%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for PSCH and PBPH.
Loading charts...
Drawdown Indicators
| PSCH | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.32% | -11.10% | -35.22% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -22.98% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -46.32% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -46.32% | — | — |
Current DrawdownCurrent decline from peak | -30.59% | -8.69% | -21.90% |
Average DrawdownAverage peak-to-trough decline | -13.46% | -4.23% | -9.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.54% | — | — |
Volatility
PSCH vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| PSCH | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.19% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 14.06% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 20.26% | 16.78% | +3.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 16.78% | +6.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.63% | 16.78% | +6.85% |
PSCH vs. PBPH - Expense Ratio Comparison
PSCH has a 0.29% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
PSCH vs. PBPH - Dividend Comparison
PSCH's dividend yield for the trailing twelve months is around 0.01%, less than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% |
Frequently Asked Questions
PSCH and PBPH have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.29% for PSCH.
PBPH has the higher dividend yield at 0.09%, compared with 0.01% for PSCH.
PSCH tracks S&P SmallCap 600 Health Care Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Invesco and Portfolio Building Block. Their fees differ too: 0.29% for PSCH and 0.13% for PBPH.
Find the right allocation for PSCH and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer